ATRC

Insider trade Sale by Prange Karen

11d ago

News AtriCure gains China's nod for heart surgery device - Investing.com

14d ago

Insider trade Sale by Doraiswamy Vinayak (Chief Scientific Officer)

14d ago

News AtriCure reiterates 2026 revenue $600M-$610M as BoxX-NoAF enrollment targets year-end completion

27d ago

SEC filing ATRC Reports $141.2M Q1 Rev, $0.1M Net Income, $17.1M Adj EBITDA, 14.3% YoY Growth, $600M-610M FY26 Rev Guidance

27d ago

Insider trade Sale by Vinayak Doraiswamy (Chief Scientific Officer)

78d ago

News AtriCure targets 12%-14% revenue growth in 2026 as innovation and clinical progress drive momentum

104d ago

News Powerlaw Listing to Give Investors Access to Anthropic, SpaceX

104d ago

News AtriCure slides 15% after JPMorgan downgrades over Edwards competition

111d ago